杭州園林(300649.SZ):聯合體中標1.46億元鹽城市濕地公園EPC工程總承包項目
格隆匯 9 月 9日丨杭州園林(300649.SZ)公佈,2020年9月9日,公司收到鹽城市鐵路投資發展有限公司發來的《中標通知書》。通知書確認公司作為聯合體牽頭人為鹽城市濕地公園EPC工程總承包項目的中標人。
項目名稱:鹽城市濕地公園EPC工程總承包;中標價格:約1.46億元;建設內容及規模:規劃範圍總面積為44.13公頃,包含但不限於紅線範圍內西至城際鐵路,東至通榆河,南至青年路高架,北至建軍路,工程EPC總承包的設計、施工、設備材料採購及安裝直至竣工驗收合格、質保期內的保修等全部工作。該工程總工期為120日曆天(含法定節假日時間)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.